Cart
sales@molnova.com
Valbenazine
CAS No. 1025504-45-3
Valbenazine( NBI-98854 )
Catalog No. M10117 CAS No. 1025504-45-3
A novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 60 | In Stock |
|
| 5MG | 122 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 402 | In Stock |
|
| 50MG | 582 | In Stock |
|
| 100MG | 831 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameValbenazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.
-
DescriptionA novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.Other Indication Phase 3 Clinical(In Vitro):Valbenazine exhibits VMAT2 binding affinity in rat striatum and human platelets with Kis of 110 and 150 nM, respectively. (In Vivo):Valbenazine (10 mg/kg; orally) induces ptosis (primarily an adrenergic response) and increases plasma prolactin primarily a dopaminergic response.
-
In Vitro——
-
In Vivo——
-
SynonymsNBI-98854
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number1025504-45-3
-
Formula Weight418.5695
-
Molecular FormulaC24H38N2O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC
-
Chemical NameL-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Murine CMV pp 89 (16...
IE1 peptide refers to an antigenic peptide encoded by the immediate early (IE) gene of mouse cytomegalovirus (mCMV). IE1 peptide is one of the key antigenic peptides expressed during mCMV infection, plays a role in transcriptional activation in the life cycle of mCMV, and is one of the earliest genes expressed in the viral replication cycle. IE1 peptide is an important target for CD8+ T cell response and can be used to study the host immune response to mCMV infection.
-
PLP 139-151
PLP (139-151) is amino acid residue residue 139 to 151 of myelin proteolipid protein (PLP). This peptide is used to induce relapsing-remitting (RR)-EAE model.
-
Astaxanthin
Astaxanthin is a natural dietary component. Natural astaxanthin is generally recognized as safe (GRAS) by the FDA
